Israel Active

Save a Child’s Heart, operating out of the International Pediatric Cardiac Center and Sylvan Adams Children’s Hospital at Wolfson Medical Center, has performed its 8,000th life-saving heart surgery for a child from Africa. Plus training African doctors to save lives. Please watch the video.

Physicians at Jerusalem’s Shaare Zedek Medical Center say a chicken bone lurking in a man’s soup caused a blockage in his lung. This led to an infection that nearly killed him. After medication failed to clear the infection and his severe cough, a bronchoscopy revealed the cause.

Israeli-invented CAR-T immunotherapy, which re-arms T-cells with synthetic receptors to seek and destroy malignant cells, has already changed the outlook for several blood cancers worldwide and is steadily expanding in Israeli hospitals through tightly regulated clinical programs.

Israel’s BioLineRX (see previously) has partnered with Norway’s Hemispherian to develop GLIX1, a first-in-class, oral, small molecule targeting DNA damage response in glioblastoma and other cancers.

Scientists at Israel’s Technion Institute used low-frequency sounds in Pink Floyd’s “Another Brick in the Wall” to make cells ‘vibrate’ and parts of the brain to ‘light up’. This then released proteins that helped get medication across the blood-brain barrier. Thanks for helping Israel, Roger.

A new video featuring Israel’s i-BrainTech (see previously) showing how their system allows athletes to focus their minds to improve their physical skills.

Israeli medical NGO United Hatzalah has launched a pilot of its new electric ambu-scooters. These will get UH medics to medical emergencies even faster. What next – medics on electric skates?

A head-to-head study by Israel's Technion found that CollPlant's rhCollagen-based bioink, Collink.3D™, outperformed Matrigel®, a leading extracellular matrix, in supporting structured tissue formation. CollPlant's sustainable vegan ink advances regenerative medicine and tissue modeling.

ProSpecBio has launched its latest product: CHO cell–derived recombinant Activin-A, now available for immediate delivery worldwide.  Activin-A is increasingly recognized as a potential therapeutic agent for conditions such as brain injury and inflammatory diseases.

Researchers at Israel’s Bar-Ilan University are working on Project HepaModulatoR with the University of Tübingen, Germany to correct damaged RNA causing chronic liver diseases. They have been awarded a multi-million Euro grant from the European Research Council.